Microbot Medical Inc diskutieren
Microbot Medical Inc
WKN: A2N5AS / Symbol: STEM / Name: Microbot Medical / Aktie / Micro Cap /
0,83 €
3,51 %
Buy Microbot Medical Inc
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at Morgan Stanley from $15.00 to $12.00. They now have an "overweight" rating on the stock.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $5.00 price target on the stock, down previously from $9.00.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at TD Cowen from $11.00 to $8.00. They now have an "outperform" rating on the stock.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at Susquehanna from $5.50 to $4.00. They now have a "positive" rating on the stock.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at Evercore ISI from $13.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at UBS Group AG from $5.00 to $2.50. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at Evercore ISI from $9.00 to $5.00. They now have an "outperform" rating on the stock.
Ratings data for STEM provided by MarketBeat
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at UBS Group AG from $2.50 to $1.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat
Neueste Beiträge
Bank_of_America_Co_ in Boise Cascade Co diskutieren